Ceramide, a target for antiretroviral therapy

被引:89
作者
Finnegan, CM
Rawat, SS
Puri, A
Wang, JM
Ruscetti, FW
Blumenthal, R
机构
[1] NCI, Lab Expt & Computat Biol, Ctr Canc Res, NIH, Frederick, MD 21702 USA
[2] NCI, Mol Immunoregulat Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA
[3] NCI, Expt Immunol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA
关键词
D O I
10.1073/pnas.0402874101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Studies of ceramide metabolism and function in a wide range of biological processes have revealed a role for this lipid in regulating key cellular responses. Our research on the role of sphingolipids in HIV entry has led to the hypothesis that modulation of ceramide levels in target cells affects their susceptibility to HIV infection by rearranging HIV receptors. Cellular ceramide levels were modulated by application of pharmacological agents such as N-(4-hydroxyphenyl)retinamide (4-HPR, fenretinide), by treatment with sphingomyelinase (Smase), or by exogenous addition of long-chain ceramide, and determined after metabolic incorporation of [H-3]sphingosine. Infectivity assays were performed by using a HeLa-derived indicator cell line, TZM-bl, CD4(+) lymphocytes, and monocytes. We observed a dose-dependent inhibition by 4-HPR of infection of TZM-bl cells by a broad range of HIV-1 isolates at low micromolar concentrations with an IC50 Of < 1 muM for most isolates tested. Nearly complete inhibition was seen at 5 muM, a dose that enhanced ceramide levels by 50-100%, yet was nontoxic to the cells. Treating cells with other pharmacological agents that enhanced ceramide levels, with Smase, or exogenous addition of long-chain ceramide also resulted in inhibition of HIV-1 infection. Enhancing ceramide levels in CD4(+) lymphocytes and in monocytederived macrophages with 4-HPR or Smase significantly reduced infectivity without toxicity. The minimal toxicity of normal cells exposed to 4-HPR should make the drug exceedingly suitable as an anti-HIV therapeutic.
引用
收藏
页码:15452 / 15457
页数:6
相关论文
共 28 条
[1]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[2]   CERAMIDE SYNTHASE MEDIATES DAUNORUBICIN-INDUCED APOPTOSIS - AN ALTERNATIVE MECHANISM FOR GENERATING DEATH SIGNALS [J].
BOSE, R ;
VERHEIJ, M ;
HAIMOVITZFRIEDMAN, A ;
SCOTTO, K ;
FUKS, Z ;
KOLESNICK, R .
CELL, 1995, 82 (03) :405-414
[3]   Lipid rafts and HIV-1: from viral entry to assembly of progeny virions [J].
Campbell, SM ;
Crowe, SM ;
Mak, J .
JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (03) :217-227
[4]  
Carrer DC, 1999, J LIPID RES, V40, P1978
[5]   A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes [J].
Cavrois, M ;
de Noronha, C ;
Greene, WC .
NATURE BIOTECHNOLOGY, 2002, 20 (11) :1151-1154
[6]   Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? [J].
Cremesti, AE ;
Goni, FM ;
Kolesnick, R .
FEBS LETTERS, 2002, 531 (01) :47-53
[7]   Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains [J].
del Real, G ;
Jiménez-Baranda, S ;
Lacalle, RA ;
Mira, E ;
Lucas, P ;
Gómez-Moutón, C ;
Carrera, AC ;
Martinez-A, C ;
Mañes, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :293-301
[8]  
FORMELLI F, 1993, CANCER RES, V53, P5374
[9]   The HIV Env-mediated fusion reaction [J].
Gallo, SA ;
Finnegan, CM ;
Viard, M ;
Raviv, Y ;
Dimitrov, A ;
Rawat, SS ;
Puri, A ;
Durell, S ;
Blumenthal, R .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1614 (01) :36-50
[10]   Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts [J].
Grassmé, H ;
Jendrossek, V ;
Riehle, A ;
von Kürthy, G ;
Berger, J ;
Schwarz, H ;
Weller, M ;
Kolesnick, R ;
Gulbins, E .
NATURE MEDICINE, 2003, 9 (03) :322-330